Cargando…

In vitro Synergism of Six Antituberculosis Agents Against Drug-Resistant Mycobacterium tuberculosis Isolated from Retreatment Tuberculosis Patients

BACKGROUND: Retreatment tuberculosis (TB) has become a major source of drug-resistant TB. In contrast to the combination of isoniazid (INH) and rifampicin (RIF), that of pasiniazid (Pa) and rifabutin (RFB) or rifapentine (RFP) appears to have better activity in vitro against drug-resistant Mycobacte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ying, Ruoyan, Huang, Xiaochen, Gao, Yaxian, Wang, Jie, Liu, Yidian, Sha, Wei, Yang, Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449861/ https://www.ncbi.nlm.nih.gov/pubmed/34548797 http://dx.doi.org/10.2147/IDR.S322563

Ejemplares similares

Metabolic Profiles of Clinical Isolates of Drug-Susceptible and Multidrug-Resistant Mycobacterium tuberculosis: A Metabolomics-Based Study
por: Wang, Li, et al.
Publicado: (2023)

Mycobacterium tuberculosis resistance to antituberculosis drugs in Mozambique,
por: Pires, Germano Manuel, et al.
Publicado: (2014)

Activity of Riminophenazines against Mycobacterium tuberculosis: A Review of Studies that Might be Contenders for Use as Antituberculosis Agents
por: Bvumbi, Mpelegeng Victoria
Publicado: (2020)

Pattern of drug resistance of Mycobacterium tuberculosis clinical isolates to first-line antituberculosis drugs in pulmonary cases
por: Kalo, Deepika, et al.
Publicado: (2015)

Mycobacterium tuberculosis Specific CD8(+) T Cells Rapidly Decline with Antituberculosis Treatment
por: Nyendak, Melissa R., et al.
Publicado: (2013)

Mycobacterium tuberculosisβ-Carbonic Anhydrases: Novel Targets for Developing Antituberculosis Drugs
por: Aspatwar, Ashok, et al.
Publicado: (2019)

Initial second-line drug resistance of Mycobacterium tuberculosis isolates from Sudanese retreatment-patients
por: Adam, Muatsim Ahmed Mohammed, et al.
Publicado: (2017)

Evaluation of crystal violet decolorization assay for minimal inhibitory concentration detection of primary antituberculosis drugs against Mycobacterium tuberculosis isolates
por: Coban, Ahmet Yilmaz, et al.
Publicado: (2016)

Combination Effect of Antituberculosis Drugs and Ethanolic Extract of Selected Medicinal Plants against Multi-Drug Resistant Mycobacterium tuberculosis Isolates
por: Fauziyah, Prabasiwi Nur, et al.
Publicado: (2017)

Plasma host protein signatures correlating with Mycobacterium tuberculosis activity prior to and during antituberculosis treatment
por: Ndiaye, Mame Diarra Bousso, et al.
Publicado: (2022)

The retreat of tuberculosis 1850–1950
por: Rosenkrantz, Barbara Gutmann
Publicado: (1990)

Toward antituberculosis drugs: in silico screening of synthetic compounds against Mycobacterium tuberculosis l,d-transpeptidase 2
por: Billones, Junie B, et al.
Publicado: (2016)

Wollamide Cyclic Hexapeptides Synergize with Established and New Tuberculosis Antibiotics in Targeting Mycobacterium tuberculosis
por: Rollo, Rachel F., et al.
Publicado: (2023)

The Effect of an Antituberculosis Serum on the Development of Experimental Tuberculosis of the Skin
por: Thomas, Robert M., et al.
Publicado: (1940)

Adverse Reactions to Antituberculosis Drugs in Iranian Tuberculosis Patients
por: Farazi, Aliasghar, et al.
Publicado: (2014)

Epidemiology of tuberculosis and susceptibility to antituberculosis drugs in Reunion Island
por: Loukman, Moreea, et al.
Publicado: (2023)

In vitro antifungal susceptibility of yeasts and molds isolated from sputum of tuberculosis relapse and retreatment patients
por: Tonui, Josephat, et al.
Publicado: (2021)

Resistance To First-Line Antituberculosis Drugs And Prevalence Of pncA Mutations In Clinical Isolates Of Mycobacterium tuberculosis From Zunyi, Guizhou Province Of China
por: Cao, Zhimin, et al.
Publicado: (2019)

Putting Tuberculosis (TB) To Rest: Transformation of the Sleep Aid, Ambien, and “Anagrams” Generated Potent Antituberculosis Agents
por: Moraski, Garrett C., et al.
Publicado: (2014)

In Vitro Isolation and Characterization of Oxazolidinone-Resistant Mycobacterium tuberculosis
por: McNeil, Matthew B., et al.
Publicado: (2017)

Bioorthogonal Correlative Light-Electron Microscopy of Mycobacterium tuberculosis in Macrophages Reveals the Effect of Antituberculosis Drugs on Subcellular Bacterial Distribution
por: Bakkum, Thomas, et al.
Publicado: (2020)

Targeting dendritic cells with TLR-2 ligand–coated nanoparticles loaded with Mycobacterium tuberculosis epitope induce antituberculosis immunity
por: Kumar Das, Deepjyoti, et al.
Publicado: (2022)

Mechanism of Action, Resistance, Synergism, and Clinical Implications of Delamanid Against Multidrug-Resistant Mycobacterium tuberculosis
por: Khoshnood, Saeed, et al.
Publicado: (2021)

Antimycobacterial Activity, Synergism, and Mechanism of Action Evaluation of Novel Polycyclic Amines against Mycobacterium tuberculosis
por: Kapp, Erika, et al.
Publicado: (2021)

Tuberculosis retreatment ‘others’ in comparison with classical retreatment cases; a retrospective cohort review
por: Nabukenya-Mudiope, Mary G., et al.
Publicado: (2015)

Genomic characteristics of Mycobacterium tuberculosis isolates of cutaneous tuberculosis
por: Mei, You-Ming, et al.
Publicado: (2023)

In silico identification of novel chemical compounds with antituberculosis activity for the inhibition of InhA and EthR proteins from Mycobacterium tuberculosis
por: Halder, Sajal Kumar, et al.
Publicado: (2021)

Novel MenA Inhibitors Are Bactericidal against Mycobacterium tuberculosis and Synergize with Electron Transport Chain Inhibitors
por: Berube, Bryan J., et al.
Publicado: (2019)

Characteristics and Treatment Outcomes of Retreatment Tuberculosis Patients in Benin
por: Ade, Serge, et al.
Publicado: (2016)

Drug-susceptibility Patterns of Mycobacterium tuberculosis in Mpumalanga Province, South Africa: Possible Guiding Design of Retreatment Regimen
por: Green, E., et al.
Publicado: (2010)

Population Pharmacokinetics of the Antituberculosis Agent Pretomanid
por: Salinger, David H., et al.
Publicado: (2019)

Pharmacokinetics of antituberculosis drugs in critically ill patients with tuberculosis and acute respiratory failure
por: Hernandez-Cardenas, CH, et al.
Publicado: (2014)

The Expression of lncRNA NEAT1 in Human Tuberculosis and Its Antituberculosis Effect
por: Huang, Shuying, et al.
Publicado: (2018)

Transcriptional Profile of Mycobacterium tuberculosis in an in vitro Model of Intraocular Tuberculosis
por: Abhishek, Sudhanshu, et al.
Publicado: (2018)

Competitive Fitness of Mycobacterium tuberculosis in vitro
por: Kodio, Ousmane, et al.
Publicado: (2019)

Drug resistance patterns of Mycobacterium tuberculosis complex and associated factors among retreatment cases around Jimma, Southwest Ethiopia
por: Abdella, Kedir, et al.
Publicado: (2015)

Molecular diversity of Mycobacterium tuberculosis isolates from patients with tuberculosis in Honduras
por: Rosales, Senia, et al.
Publicado: (2010)

Cytokine Polymorphisms, Their Influence and Levels in Brazilian Patients with Pulmonary Tuberculosis during Antituberculosis Treatment
por: Peresi, Eliana, et al.
Publicado: (2013)

Antituberculosis Drug-Induced Hepatotoxicity in IranianTuberculosis Patients: Role of Isoniazid Metabolic Polymorphism
por: Sistanizad, Mohammad, et al.
Publicado: (2011)

Early antituberculosis drug exposure in hospitalized patients with human immunodeficiency virus‐associated tuberculosis
por: Schutz, Charlotte, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pp11njmvg1q83js70e9alqc0u5